![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0083.png)
1999 AMERICAN BRACHYTHERAPY SOCIETY (ABS)
RECOMMENDATIONS FOR TRANSPERINEAL PERMANENT
BRACHYTHERAPY OF PROSTATE CANCER
•
Clinical Exclusion Criteria:
•
Life expectancy < 5 years
•
Large or poorly healed TURP defect
•
Unacceptable operative risks
•
Distant metastases